The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Glucose-6-phosphatase deficiency
Open accessAbstract
Glucose-6-phosphatase deficiency (G6P deficiency), or glycogen storage disease type I (GSDI), is a group of inherited metabolic diseases, including types Ia and Ib, characterized by poor tolerance to fasting, growth retardation and hepatomegaly resulting from accumulation of glycogen and fat in the liver. Prevalence is unknown and annual incidence is around 1/100,000 births. GSDIa is the more frequent type, representing about 80% of GSDI patients. The disease commonly manifests, between the ages of 3 to 4 months by symptoms of hypoglycemia (tremors, seizures, cyanosis, apnea). Patients have poor tolerance to fasting, marked hepatomegaly, growth retardation (small stature and delayed puberty), generally improved by an appropriate diet, osteopenia and sometimes osteoporosis, full-cheeked round face, enlarged kydneys and platelet dysfunctions leading to frequent epistaxis. In addition, in GSDIb, neutropenia and neutrophil dysfunction are responsible for tendency towards infections, relapsing aphtous gingivostomatitis, and inflammatory bowel disease. Late complications are hepatic (adenomas with rare but possible transformation into hepatocarcinoma) and renal (glomerular hyperfiltration leading to proteinuria and sometimes to renal insufficiency). GSDI is caused by a dysfunction in the G6P system, a key step in the regulation of glycemia. The deficit concerns the catalytic subunit G6P-alpha (type Ia) which is restricted to expression in the liver, kidney and intestine, or the ubiquitously expressed G6P transporter (type Ib). Mutations in the genes G6PC(17q21) and SLC37A4(11q23) respectively cause GSDIa and Ib. Many mutations have been identified in both genes,. Transmission is autosomal recessive. Diagnosis is based on clinical presentation, on abnormal basal values and absence of hyperglycemic response to glucagon. It can be confirmed by demonstrating a deficient activity of a G6P system component in a liver biopsy. To date, the diagnosis is most commonly confirmed by G6PC(GSDIa) or SLC37A4(GSDIb) gene analysis, and the indications of liver biopsy to measure G6P activity are getting rarer and rarer. Differential diagnoses include the other GSDs, in particular type III (see this term). However, in GSDIII, glycemia and lactacidemia are high after a meal and low after a fast period (often with a later occurrence than that of type I). Primary liver tumors and Pepper syndrome (hepatic metastases of neuroblastoma) may be evoked but are easily ruled out through clinical and ultrasound data. Antenatal diagnosis is possible through molecular analysis of amniocytes or chorionic villous cells. Pre-implantatory genetic diagnosis may also be discussed. Genetic counseling should be offered to patients and their families. The dietary treatment aims at avoiding hypoglycemia (frequent meals, nocturnal enteral feeding through a nasogastric tube, and later oral addition of uncooked starch) and acidosis (restricted fructose and galactose intake). Liver transplantation, performed on the basis of poor metabolic control and/or hepatocarcinoma, corrects hypoglycemia, but renal involvement may continue to progress and neutropenia is not always corrected in type Ib. Kidney transplantation can be performed in case of severe renal insufficiency. Combined liver-kidney grafts have been performed in a few cases. Prognosis is usually good: late hepatic and renal complications may occur, however, with adapted management, patients have almost normal life span. Disease name and synonyms Glucose-6-phosphatase deficiency or G6P deficiency or glycogen storage disease type I or GSDI or type I glycogenosis or Von Gierke disease or Hepatorenal glycogenosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zucman-Rossi, J., Jeannot, E., Van Nhieu, J. T., Scoazec, J.-Y., Guettier, C., Rebouissou, S., Bacq, Y., Leteurtre, E., Paradis, V., Michalak, S., et al. (2006) · Hepatology · doi:10.1002/hep.21068 · Cited by 760
Weinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632
The glucose-6-phosphatase system
SCHAFTINGEN, E. V., & Gerin, I. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620513 · Cited by 495
Rake, J. P., Visser, G., Labrune, P., Leonard, J. V., Ullrich, K., & Smit, G. P. A. (2002) · European Journal of Pediatrics · doi:10.1007/bf02679990 · Cited by 424
Self-citationMutations in the Glucose-6-Phosphatase Gene that Cause Glycogen Storage Disease Type 1a
Lei, K.-J., Shelly, L. L., Pan, C.-J., Sidbury, J. B., & Chou, J. Y. (1993) · Science · doi:10.1126/science.8211187 · Cited by 377
Inborn Metabolic Diseases: Diagnosis and Treatment
(2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8 · Cited by 361
A Syndrome with Congenital Neutropenia and Mutations in G6PC3
Boztug, K., Appaswamy, G., Ashikov, A., Schäffer, A. A., Salzer, U., Diestelhorst, J., Germeshausen, M., Brandes, G., Lee-Gossler, J., Noyan, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805051 · Cited by 353
Labrune, P., Trioche, P., Duvaltier, I., Chevalier, P., & Odièvre, M. (1997) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1997.tb00424.x · Cited by 311
Self-citationArion, W. J., Lange, A. J., Walls, H. E., & Ballas, L. M. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70478-5 · Cited by 265
Rake, J. P., Visser, G., Labrune, P., Leonard, J. V., Ullrich, K., & Smit, G. P. A. (2002) · European Journal of Pediatrics · doi:10.1007/bf02680007 · Cited by 254
Self-citation
Cited by
Kishnani, P. S., Austin, S. L., Abdenur, J. E., Arn, P., Bali, D. S., Boney, A., Chung, W. K., Dagli, A. I., Dale, D., Koeberl, D., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.128 · Cited by 499
Liver glucose metabolism in humans
Adeva-Andany, M. M., Pérez-Felpete, N., Fernández-Fernández, C., Donapetry-García, C., & Pazos-García, C. (2016) · Bioscience Reports · doi:10.1042/bsr20160385 · Cited by 372
Squires, R. H., Ng, V., Romero, R., Ekong, U., Hardikar, W., Emre, S., & Mazariegos, G. V. (2014) · Hepatology · doi:10.1002/hep.27191 · Cited by 254
Roseman, D. S., Khan, T., Rajas, F., Jun, L. S., Asrani, K. H., Isaacs, C., Farelli, J. D., & Subramanian, R. R. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.01.006 · Cited by 72
A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia
Zhou, J., Waskowicz, L. R., Lim, A., Liao, X.-H., Lian, B., Masamune, H., Refetoff, S., Tran, B., Koeberl, D. D., & Yen, P. M. (2019) · Thyroid® · doi:10.1089/thy.2019.0007 · Cited by 60
Metadata
- Authors
- Froissart, R., Piraud, M., Boudjemline, A. M., Vianey-Saban, C., Petit, F., Hubert-Buron, A., Eberschweiler, P. T., Gajdos, V., & Labrune, P.
- Venue
- Orphanet Journal of Rare Diseases
- Published
- 2011-05-20
- Volume
- 6
- Issue
- 1
- Pages
- 27-27
- ISSN
- 1750-1172 (ISSN-L)
- OpenAlex
- W2137566647
- Cited by
- 265
- References
- 68
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucose-6-phosphatase deficiency. https://app.cochat.ai/papers/10.1186/1750-1172-6-27
- The paper
- Froissart, R., Piraud, M., Boudjemline, A. M., Vianey-Saban, C., Petit, F., Hubert-Buron, A., Eberschweiler, P. T., Gajdos, V., & Labrune, P. (2011). Glucose-6-phosphatase deficiency. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-6-27
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.